ARKK Holdings of Verve Therapeutics (VERV) - Updated Daily
Gene TherapyGenomicsCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
0.5% | $1.10b |
🏋🏿♂️Weight Rank In ARKK | 🌏Country |
32 | 🇺🇸United States |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
35 | $28.17 |
🎫ARK Ownership Percent | |
3.52% |
Other ETFs That Hold VERV
Research Notes and Commentary for VERV
No Research Notes Found for VERV